<p>According to the Zhitong Finance APP, TRANSTHERA-B (02617) announced that on October 20, 2025, the company's board of directors considered and approved the application to the China Securities Regulatory Commission to convert 44.9711 million domestic shares held by 10 shareholders into H shares of the company, accounting for approximately 11.33% of the total issued shares of the company as of the date of this announcement. Upon obtaining all relevant approvals (including those from the China Securities Regulatory Commission and the Stock Exchange) and complying with all applicable laws, regulations, and rules, these domestic shares will be converted into H shares and will qualify for listing and trading on the main board of the Stock Exchange</p>

02617

<p>TRANSTHERA-B plans to apply to the China Securities Regulatory Commission on October 20, 2025, to convert 44.9711 million domestic shares held by 10 shareholders into H shares, accounting for approximately 11.33% of the total issued shares. This conversion requires relevant approvals and must meet the qualifications for listing and trading on the Main Board of the Stock Exchange</p>

TRANSTHERA-B plans to implement full circulation of H shares